Access to antibiotics: not a problem in some LMICs

  16 April 2021

Poor access to antibiotics is estimated to cause substantial morbidity and mortality due to pneumonia and acute febrile illness among children younger than 5 years, with most of these events happening in low-income and middle-income countries (LMICs). However, a study set in eight LMICs showed that children received around 25 antibiotic prescriptions for respiratory tract infection or fever during their first 5 years of life, and most of these prescriptions were deemed inappropriate. This conflicting finding calls for better understanding of issues surrounding antibiotic access and use in LMICs, because these countries simultaneously face high burdens of antimicrobial resistance.

Further reading: The Lancet Global Health
Author(s): Giorgia Sulis, Sumanth Gandra
Effective Surveillance  


Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified

Technology Database

Display your AMR Technology, Product and Service


Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.


Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!